Skip to main content
PHR
NYSE Trade & Services

Phreesia Q2 10-Q: $1.9M Net Income, Data Breach Settlement, and CEO Trading Plan

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$10.85
Mkt Cap
$686.112M
52W Low
$7.77
52W High
$31.38
52W Position info
40% above low
Off High info
65% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

PHR sits 40% above its 52-week low of $7.77.

Summary

Phreesia filed its Q2 FY2027 10-Q confirming $1.9M net income and $32.9M Adjusted EBITDA, while disclosing a $4.95M data breach settlement, two securities class actions, and a CEO trading plan for up to 200,000 shares.


Key Events · Earnings and Guidance · PHR

  • Q2 Net Income of $1.9M

    Revenue rose 10% YoY to $129.5M; Adjusted EBITDA was $32.9M. Six-month net income was $4.9M vs a $3.3M loss last year.

  • ConnectOnCall Settlement Approved

    Court granted preliminary approval July 27, 2026 for a $4.95M non-reversionary settlement fund. Phreesia recorded a $4.95M loss contingency and a matching $4.95M insurance receivable.

  • Two Securities Class Actions Pending

    Theodoulou v. Phreesia (filed May 13, 2026) and Key West v. Phreesia (filed July 13, 2026) allege 10(b)/20(a) violations. Motions for consolidation and lead plaintiff appointment are pending; loss range not estimable.

  • CEO Adopts 10b5-1 Trading Plan

    Chaim Indig adopted a plan July 13, 2026 covering potential exercise of vested options and sale of up to 200,000 shares, expiring July 10, 2028.


Analysis · PHR · Trade & Services

Phreesia's 10-Q confirms the Q2 results already previewed in the 8-K, but adds material new disclosures: a $4.95M preliminary settlement for the ConnectOnCall data breach (fully offset by insurance), two pending securities class actions, and a CEO Rule 10b5-1 plan covering up to 200,000 shares. The company also expanded its securitization facility to $300M and detailed a restructuring eliminating ~220 positions. The litigation and insider selling plan are the most market-relevant new items.

How filings like this one have moved

In the 30 days to Sep 10, 2026, 29.9% of the 1988 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PHR was trading at $10.85 on NYSE in the Trade & Services sector, with a market capitalization of approximately $686.1M. The 52-week trading range was $7.77 to $31.38. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PHR - Latest Insights

PHR
Sep 02, 2026, 4:06 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $11.65
Real-time Price: $10.15 info
Change: -$1.50 (-13%) info
Market Cap: $630.02M info
PHR
May 29, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $9.51
Real-time Price: $10.15 info
Change: +$0.640 (+7%) info
Market Cap: $630.02M info
PHR
May 28, 2026, 4:11 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $9.48
Real-time Price: $10.15 info
Change: +$0.670 (+7%) info
Market Cap: $630.02M info
PHR
May 28, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.45
Real-time Price: $10.15 info
Change: +$0.700 (+7%) info
Market Cap: $630.02M info
PHR
May 28, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $10.63
Real-time Price: $10.15 info
Change: -$0.476 (-4%) info
Market Cap: $630.02M info